Attenuating Effects of Dieckol on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Decreasing the NLRP3 Inflammasome and Pyroptosis

Mar Drugs. 2021 May 30;19(6):318. doi: 10.3390/md19060318.

Abstract

Nonalcoholic fatty liver disease (NAFLD), which promotes serious health problems, is related to the increase in the nucleotide-binding oligomerization domain-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome and pyroptosis by a high-fat diet (HFD). Whether dieckol (DK), a component of Ecklonia cava extracts (ECE), attenuated NAFLD in an HFD-induced NAFLD animal model was evaluated. The expression of high mobility group box 1/Toll-like receptor 4/nuclear factor-κB, which initiated the NLRP3 inflammasome, was increased in the liver of HFD-fed animals and significantly decreased with ECE or DK administration. The expression of NLRP3/ASC/caspase-1, which are components of the NLRP3 inflammasome, and the number of pyroptotic cells were increased by HFD and decreased with ECE or DK administration. The accumulation of triglycerides and free fatty acids in the liver was increased by HFD and decreased with ECE or DK administration. The histological NAFLD score was increased by HFD and decreased with ECE or DK administration. The expression of lipogenic genes (FASN, SREBP-2, PPARγ, and FABP4) increased and that of lipolytic genes (PPARα, CPT1A, ATGL, and HSL) was decreased by HFD and attenuated with ECE or DK administration. In conclusion, ECE or DK attenuated NAFLD by decreasing the NLRP3 inflammasome and pyroptosis.

Keywords: Ecklonia cava extract; dieckol; inflammasome; nonalcoholic fatty liver disease; pyroptosis.

MeSH terms

  • Animals
  • Benzofurans / pharmacology
  • Benzofurans / therapeutic use*
  • Carnitine O-Palmitoyltransferase / genetics
  • Diet, High-Fat
  • Gene Expression / drug effects
  • HMGB1 Protein / immunology
  • Inflammasomes / immunology
  • Lipase / genetics
  • Lipolysis / drug effects
  • Lipolysis / genetics
  • Liver / drug effects
  • Liver / immunology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • NF-kappa B / immunology
  • NLR Family, Pyrin Domain-Containing 3 Protein / immunology
  • Non-alcoholic Fatty Liver Disease / drug therapy*
  • Non-alcoholic Fatty Liver Disease / genetics
  • Non-alcoholic Fatty Liver Disease / immunology
  • PPAR alpha / genetics
  • Pyroptosis / drug effects
  • Toll-Like Receptor 4 / immunology

Substances

  • Benzofurans
  • HMGB1 Protein
  • HMGB1 protein, mouse
  • Inflammasomes
  • NF-kappa B
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Nlrp3 protein, mouse
  • PPAR alpha
  • Tlr4 protein, mouse
  • Toll-Like Receptor 4
  • dieckol
  • CPT1B protein, mouse
  • Carnitine O-Palmitoyltransferase
  • Lipase
  • PNPLA2 protein, mouse